Product
RBM-007
Aliases
RBM-007 Injectable Solution
3 clinical trials
1 indication
Indication
Age-related Macular DegenerationClinical trial
A Multi-Center, Randomized, Double Masked and Active Controlled Phase II Study Assessing the Efficacy and Safety of Intravitreal Injections of RBM-007 Monotherapy and RBM-007 in Combination With Eylea® Compared to Eylea® MonotherapyStatus: Completed, Estimated PCD: 2021-11-19
Clinical trial
A Multi-Center, Open Label, TOFU Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular DegenerationStatus: Completed, Estimated PCD: 2021-11-19
Clinical trial
Evaluation of RBM-007 in Subjects With Treatment naïve Exudative Age-related Macular Degeneration (AMD)Status: Completed, Estimated PCD: 2022-02-08